Voxel

Voxel P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Voxel (VOX.WA) as of Oct 22, 2026 is 34.84. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 27.53 — a change of 26.55% (higher).

P/FCF

34.84

YoY

26.55%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Voxel is 2025 34.84 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Voxel was 2024 27.53 . It decreases by 26.55% higher compared to the previous year.

The Voxel P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
71.37 PLN
Jan 1, 2019
62.81 PLN
Jan 1, 2020
48.32 PLN
Jan 1, 2021
19.07 PLN
Jan 1, 2022
21.84 PLN
Jan 1, 2023
19.19 PLN
Jan 1, 2024
27.53 PLN
Jan 1, 2025
34.84 PLN
The Voxel P/FCF history
YEARP/FCFYoY
34.84+26.55%
27.53+43.51%
19.19-12.16%
21.84+14.54%
19.07-60.54%
48.32-23.07%
62.81-11.99%
71.37+48.09%
48.19-55.56%
108.44+106.83%
52.43-82.95%
307.58—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Voxel Stock analysis

What does Voxel do? Voxel SA generates revenue through medical services including diagnostic imaging, teleradiology, and outsourcing, alongside IT systems for hospitals and diagnostic centers. The company serves healthcare institutions with its diagnostic imaging solutions, teleradiology services, and IT infrastructure, targeting hospitals and diagnostic centers as key clients. It operates two subsidiaries, Alteris SA (95.24%-owned) and CDO Sp. z o.o. (wholly owned), which support its service offerings. Voxel SA previously held a stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o. but sold it on November 7, 2012. The company's primary revenue streams come from providing diagnostic imaging services, teleradiology, and IT systems to healthcare facilities. Its subsidiaries, Alteris SA and CDO Sp. z o.o., contribute to the delivery of these services, enhancing its market presence in medical technology. Voxel SA focuses on institutional clients such as hospitals and diagnostic centers, leveraging its IT systems to improve operational efficiency in healthcare settings. Voxel SA's business model centers on delivering specialized medical services and technology solutions to healthcare providers. It operates through its subsidiaries, Alteris SA and CDO Sp. z o.o., to expand its service capabilities. The company's revenue is derived from contracts with hospitals and diagnostic centers for diagnostic imaging, teleradiology, and IT system implementation, with no mention of additional revenue sources beyond these core services. Voxel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Voxel stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Voxel is 34.84 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Voxel changed from 27.53 to 34.84, representing a 26.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Voxel since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Voxel with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Voxel

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Voxel